Business Wire

CEL-SCI Presents Head & Neck Cancer Data at Iddst Annual Congress in Budapest: Risk of Death Cut in Half for Patients Treated With Multikine in the Target Population

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today announced the Company’s Chief Scientific Officer, Dr. Eyal Talor, delivered a presentation titled “Neoadjuvant ...

T-knife Therapeutics Announces Four Upcoming Data Presentations on PRAME-Targeted TK-6302 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Posters will review product characterization and manufacturing data on T-knife’s lead program, TK-6302, a supercharged PRAME ...

Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema

The new long-term results follow two-month data released at ASCO in June 2025 and are drawn from the largest prospective, randomized controlled study ever conducted among head and neck cancer ...
FierceBiotech

Merus' head and neck cancer candidate bolsters 'best-in-disease' profile with new data drop: analyst

With new data on petosemtamab set to be presented at the European Society for Medical Oncology Asia Congress, Merus believes it has a potential new standard of care for head and neck squamous cell ...
STAT

Merus drug, with immunotherapy, boosts tumor response in patients with head and neck cancer

Merus said Tuesday that the combination of its experimental drug petosemtamab with the checkpoint inhibitor Keytruda shrank tumors in 62% of patients with head and neck cancer, according to an interim ...
The Badger Herald

BadgerConnect’s Research Services Fair: An afternoon designed for life science researchers

The UW Carbone Cancer Center and UW Biotechnology Center hosted the 8th annual BadgerConnect Research Services Fair Oct. 2 at ...
CURE

Buparlisib Plus Chemo Fails to Improve Head and Neck Cancer Survival

Among patients with PD-1/PD-L1-pretreated recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), treatment with ...
Morningstar

Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers

Activated b-catenin or loss of its negative regulator adenomatous polyposis coli (APC) is a potential biomarker for NT219 in the treatment of colorectal cancer NT219’s mechanism of action informs how ...
Medscape

Imaging Key to Detect Head and Neck Cancer in Dermatomyositis

Head and neck cancer (HNC) occurred in a small but distinct subgroup of patients with dermatomyositis (DM), in a retrospective study that also found that most cases presented with myositis and neck ...
Hosted on MSN

Why head and neck cancers often go undiagnosed?

Head and neck cancers are often misunderstood as being limited to oral or mouth cancer. Head and neck cancer refers to a group of cancers that develop in the head and neck region, including the oral ...